- Report
- March 2024
- 175 Pages
Global
From €4757EUR$5,000USD£4,073GBP
- Report
- March 2024
- 303 Pages
Global
From €4757EUR$5,000USD£4,073GBP
- Report
- February 2024
- 175 Pages
Global
From €4757EUR$5,000USD£4,073GBP
- Report
- February 2024
- 120 Pages
Global
From €4519EUR$4,750USD£3,870GBP
- Report
- September 2022
- 280 Pages
Global
From €4995EUR$5,250USD£4,277GBP
- Report
- May 2024
- 132 Pages
From €6184EUR$6,499USD£5,295GBP
- Report
- August 2022
- 115 Pages
Global
From €4519EUR$4,750USD£3,870GBP
- Report
- February 2019
United States
From €4277EUR$4,495USD£3,662GBP
- Report
- October 2021
- 101 Pages
Global
From €4282EUR$4,500USD£3,666GBP
- Report
- February 2021
- 27 Pages
Global
€1254EUR$1,318USD£1,074GBP
- Report
- October 2022
- 310 Pages
Global
From €3654EUR$3,840USD£3,128GBP
- Book
- December 2019
- 560 Pages
- Book
- May 2022
- 1040 Pages
- Book
- May 2022
- 1040 Pages
- Book
- December 2019
- 560 Pages
- Book
- September 2016
- 680 Pages
- Book
- April 2012
- 1272 Pages
- Book
- November 2008
- 3712 Pages
- Book
- November 2018
Africa
The Digestive Disease market is a subset of Gastroenterology, which focuses on the diagnosis and treatment of diseases related to the digestive system. This includes conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Treatment options for these conditions range from lifestyle changes and medications to more invasive procedures such as endoscopy and surgery. The market also includes products and services related to the diagnosis and treatment of digestive diseases, such as diagnostic tests, medical devices, and pharmaceuticals.
Companies in the Digestive Disease market include AbbVie, Allergan, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Takeda. Show Less Read more
